Literature DB >> 18400811

Secondary effects of antipsychotics: women at greater risk than men.

Mary V Seeman1.   

Abstract

CONTEXT: The health burden of antipsychotic medication is well known, but the disproportionate effect on women as compared with men is underappreciated.
OBJECTIVE: The goal of this article is preventive--to better inform clinicians so that the risks to women and to their offspring can be diminished.
METHOD: All PubMed sources in which the search term gender (or sex) was linked to a side effect of antipsychotic medication were reviewed. RESULT: There is general agreement in the literature on women's increased susceptibility to weight gain, diabetes, and specific cardiovascular risks of antipsychotics, with less consensus on malignancy risks and risks to the fetus. Cardiovascular death, to which men are more susceptible than women, is disproportionately increased in women by the use of antipsychotics. Sedating antipsychotics raise the risk of embolic phenomena during pregnancy, and postpartum. Prolactin-elevating drugs suppress gonadal hormone secretion and may enhance autoimmune proclivity.
CONCLUSIONS: Clinicians need to be aware of the differential harm that women (and their offspring) can incur from the side effects of antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400811      PMCID: PMC2728808          DOI: 10.1093/schbul/sbn023

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  116 in total

1.  Impact of body weight on blood pressure with a focus on sex differences: the Tromso Study, 1986-1995.

Authors:  T Wilsgaard; H Schirmer; E Arnesen
Journal:  Arch Intern Med       Date:  2000-10-09

2.  Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification.

Authors:  Joel G Ray; Philip R Wyatt; Marian J Vermeulen; Chris Meier; David E C Cole
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

3.  The effects of novel antipsychotics on glucose and lipid levels.

Authors:  Donna A Wirshing; Jennifer A Boyd; Laura R Meng; Jacob S Ballon; Stephen R Marder; William C Wirshing
Journal:  J Clin Psychiatry       Date:  2002-10       Impact factor: 4.384

4.  Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study.

Authors:  G L Zornberg; H Jick
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

Review 5.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome.

Authors:  Richard M Cubbon; Adil Rajwani; Afroze Abbas; Christopher P Gale; Peter J Grant; Stephen B Wheatcroft; Julian H Barth; Mark T Kearney; Alistair S Hall
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-10

Review 7.  Physical illness and schizophrenia: a review of the literature.

Authors:  S Leucht; T Burkard; J Henderson; M Maj; N Sartorius
Journal:  Acta Psychiatr Scand       Date:  2007-11       Impact factor: 6.392

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes.

Authors:  Andrea Guerin; Rosane Nisenbaum; Joel G Ray
Journal:  Diabetes Care       Date:  2007-04-19       Impact factor: 19.112

10.  Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.

Authors:  Christine Friedenreich; Anne Cust; Petra H Lahmann; Karen Steindorf; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sylvie Mesrine; Jakob Linseisen; Sabine Rohrmann; Heiner Boeing; Tobias Pischon; Anne Tjønneland; Jytte Halkjaer; Kim Overvad; Michelle Mendez; M L Redondo; Carmen Martinez Garcia; Nerea Larrañaga; María-José Tormo; Aurelio Barricarte Gurrea; Sheila Bingham; Kay-Tee Khaw; Naomi Allen; Tim Key; Antonia Trichopoulou; Effie Vasilopoulou; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Amalia Mattiello; Paolo Vineis; H Bas Bueno-de-Mesquita; Petra H M Peeters; Göran Berglund; Jonas Manjer; Eva Lundin; Annekatrin Lukanova; Nadia Slimani; Mazda Jenab; Rudolf Kaaks; Elio Riboli
Journal:  Cancer Causes Control       Date:  2007-02-12       Impact factor: 2.506

View more
  34 in total

1.  Gender differences in antipsychotics prescribed to veterans with serious mental illness.

Authors:  Elana Schwartz; Melanie Charlotte; Eric Slade; Deborah Medoff; Lan Li; Lisa Dixon; Amy Kilbourne; Julie Kreyenbuhl
Journal:  Gen Hosp Psychiatry       Date:  2015-04-01       Impact factor: 3.238

2.  Comparison of Sexual Function and Hormonal Parameters Between Mood Stabilizer Treatment Modalities in Bipolar Disorder.

Authors:  Sermin Kesebir; Burak Toprak; Burak Baykaran; Aytül Hariri; Mustafa Bilici
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

3.  Brain stem as a target site for the metabolic side effects of olanzapine.

Authors:  Imran J Anwar; Kayoko Miyata; Andrea Zsombok
Journal:  J Neurophysiol       Date:  2015-12-30       Impact factor: 2.714

4.  Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.

Authors:  Ashleigh L Osborne; Nadia Solowij; Ilijana Babic; Xu-Feng Huang; Katrina Weston-Green
Journal:  Neuropsychopharmacology       Date:  2017-02-23       Impact factor: 7.853

5.  Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population.

Authors:  Patrick M Azcarate; Alysandra J Zhang; Salomeh Keyhani; Stacey Steigerwald; Julie H Ishida; Beth E Cohen
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

Review 6.  Does Gender Influence Outcome in Schizophrenia?

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2019-03

7.  Predictors of outcome in brief cognitive behavior therapy for schizophrenia.

Authors:  Alison Brabban; Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-07-01       Impact factor: 9.306

8.  Gender differences in mood stabilizer medications prescribed to Veterans with serious mental illness.

Authors:  Melanie Charlotte; Elana Schwartz; Eric Slade; Deborah Medoff; Lan Li; Lisa Dixon; Amy M Kilbourne; Julie Kreyenbuhl
Journal:  J Affect Disord       Date:  2015-09-03       Impact factor: 4.839

9.  Why sex differences in schizophrenia?

Authors:  Rena Li; Xin Ma; Gang Wang; Jian Yang; Chuanyue Wang
Journal:  J Transl Neurosci (Beijing)       Date:  2016-09

10.  Pharmacokinetic patterns of risperidone-associated adverse drug reactions.

Authors:  Georgios Schoretsanitis; Benedikt Stegmann; Christoph Hiemke; Gerhard Gründer; Koen R J Schruers; Sebastian Walther; Sarah E Lammertz; Ekkehard Haen; Michael Paulzen
Journal:  Eur J Clin Pharmacol       Date:  2016-07-04       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.